An epithelial-to-mesenchymal transcriptional switch triggers evolution of pulmonary sarcomatoid carcinoma (PSC) and identifies dasatinib as new therapeutic option

G. Manzotti, F. Torricelli, D. Benedetta, F. Lococo, V. Sancisi, G. Rossi, S. Piana, A. Ciarrocchi

Research output: Contribution to journalArticle

Original languageEnglish
Pages (from-to)2348-2360
Number of pages13
JournalClinical Cancer Research
Issue number7
Publication statusPublished - 2019

Cite this